Long-term treatment of autosomal dominant polycystic kidney disease (ADPKD) with venglustat
Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early versus delayed treatment with venglustat (GZ/SAR402671) in patients at risk of rapidly progressive autosomal dominant polycystic kidney disease (ADPKD) - STAGED-PKD-EXT Multicenter, open-label, extension study to characterize the long-term efficacy and safety of early ...
Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: Congenital cystic kidney disease;System Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Congenital cystic kidney disease MedDRA version: 20.0;Level: PT;Classification code 10010428;Term: C ...